Liver resection for hepatocellular carcinoma in patients with hematological malignancies

Liver resection for hepatocellular carcinoma in patients with hematological malignancies

Abstract Background Improvements in antimetabolite drugs have prolonged the survival of patient with hematological malignancies. However, these drugs may have hepatotoxic side effects and may induce acute liver failure, chronic liver fibrosis, cirrhosis, or even hepatocellular carcinoma (HCC). Altho...

Full description

Bibliographic Details
Main Authors: Hui-Chen Lin, Yang-Shen Yang, Chieh-Lin Jerry Teng, Ching-Hui Shen, Yee-Gee Jan, Shao-Bin Cheng, Cheng-Chung Wu, Yi-Ling Lin, Chu-Chun Huang, Fang-Ku P’eng
Format: Article
Language:English
Published: BMC 2017-11-01
Series:World Journal of Surgical Oncology
Subjects:
Hepatocellular carcinoma
Liver resection
Hematological malignancy
Online Access:http://link.springer.com/article/10.1186/s12957-017-1260-y

Internet

http://link.springer.com/article/10.1186/s12957-017-1260-y

Similar Items